Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma (original) (raw)
- Letter
- Published: 27 May 2012
- Hancheng Zheng5 na1,
- Shuyu Li6 na1,
- Ronghua Chen7 na1,
- Xiao Liu5 na1,
- Yingrui Li5,
- Nikki P Lee1,
- Wah H Lee4,
- Pramila N Ariyaratne4,
- Chandana Tennakoon2,3,
- Fabianus H Mulawadi4,
- Kwong F Wong1,8,9,10,
- Angela M Liu1,8,9,10,
- Ronnie T Poon1,
- Sheung Tat Fan1,
- Kwong L Chan1,
- Zhuolin Gong5,
- Yujie Hu5,
- Zhao Lin5,
- Guan Wang5,
- Qinghui Zhang5,
- Thomas D Barber6,
- Wen-Chi Chou6,
- Amit Aggarwal6,
- Ke Hao7,
- Wei Zhou7,
- Chunsheng Zhang7,
- James Hardwick7,11,
- Carolyn Buser7,
- Jiangchun Xu12,
- Zhengyan Kan12,
- Hongyue Dai7,
- Mao Mao11,12,
- Christoph Reinhard6,
- Jun Wang5,13,14 &
- …
- John M Luk1,8,9,10 nAff15
Nature Genetics volume 44, pages 765–769 (2012)Cite this article
- 21k Accesses
- 698 Citations
- 20 Altmetric
- Metrics details
Subjects
Abstract
To survey hepatitis B virus (HBV) integration in liver cancer genomes, we conducted massively parallel sequencing of 81 HBV-positive and 7 HBV-negative hepatocellular carcinomas (HCCs) and adjacent normal tissues. We found that HBV integration is observed more frequently in the tumors (86.4%) than in adjacent liver tissues (30.7%). Copy-number variations (CNVs) were significantly increased at HBV breakpoint locations where chromosomal instability was likely induced. Approximately 40% of HBV breakpoints within the HBV genome were located within a 1,800-bp region where the viral enhancer, X gene and core gene are located. We also identified recurrent HBV integration events (in ≥4 HCCs) that were validated by RNA sequencing (RNA-seq) and Sanger sequencing at the known and putative cancer-related TERT, MLL4 and CCNE1 genes, which showed upregulated gene expression in tumor versus normal tissue. We also report evidence that suggests that the number of HBV integrations is associated with patient survival.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
Accession codes
Primary accessions
Gene Expression Omnibus
Referenced accessions
NCBI Reference Sequence
References
- Center, M.M. & Jemal, A. International trends in liver cancer incidence rates. Cancer Epidemiol. Biomarkers Prev. 20, 2362–2368 (2011).
Article PubMed Google Scholar - But, D.Y., Lai, C.L. & Yuen, M.F. Natural history of hepatitis-related hepatocellular carcinoma. World J. Gastroenterol. 14, 1652–1656 (2008).
Article PubMed PubMed Central Google Scholar - Ishikawa, T. Clinical features of hepatitis B virus–related hepatocellular carcinoma. World J. Gastroenterol. 16, 2463–2467 (2010).
Article PubMed PubMed Central Google Scholar - Bréchot, C., Gozuacik, D., Murakami, Y. & Paterlini-Brechot, P. Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Semin. Cancer Biol. 10, 211–231 (2000).
Article PubMed Google Scholar - Zucman-Rossi, J. & Laurent-Puig, P. Genetic diversity of hepatocellular carcinomas and its potential impact on targeted therapies. Pharmacogenomics 8, 997–1003 (2007).
Article CAS PubMed Google Scholar - Gehring, A.J. et al. Profile of tumor antigen–specific CD8 T cells in patients with hepatitis B virus–related hepatocellular carcinoma. Gastroenterology 137, 682–690 (2009).
Article CAS PubMed Google Scholar - Shafritz, D.A., Shouval, D., Sherman, H.I., Hadziyannis, S.J. & Kew, M.C. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens. N. Engl. J. Med. 305, 1067–1073 (1981).
Article CAS PubMed Google Scholar - Koshy, R. et al. Integration of hepatitis B virus DNA: evidence for integration in the single-stranded gap. Cell 34, 215–223 (1983).
Article CAS PubMed Google Scholar - Brechot, C., Pourcel, C., Louise, A., Rain, B. & Tiollais, P. Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature 286, 533–535 (1980).
Article CAS PubMed Google Scholar - Chakraborty, P.R., Ruiz-Opazo, N., Shouval, D. & Shafritz, D.A. Identification of integrated hepatitis B virus DNA and expression of viral RNA in an HBsAg-producing human hepatocellular carcinoma cell line. Nature 286, 531–533 (1980).
Article CAS PubMed Google Scholar - Bonilla Guerrero, R. & Roberts, L.R. The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma. J. Hepatol. 42, 760–777 (2005).
Article CAS PubMed Google Scholar - Murakami, Y. et al. Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Gut 54, 1162–1168 (2005).
Article CAS PubMed PubMed Central Google Scholar - Paterlini-Bréchot, P. et al. Hepatitis B virus–related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene. Oncogene 22, 3911–3916 (2003).
Article PubMed Google Scholar - Gozuacik, D. et al. Identification of human cancer-related genes by naturally occurring Hepatitis B Virus DNA tagging. Oncogene 20, 6233–6240 (2001).
Article CAS PubMed Google Scholar - Saigo, K. et al. Integration of hepatitis B virus DNA into the myeloid/lymphoid or mixed-lineage leukemia (MLL4) gene and rearrangements of MLL4 in human hepatocellular carcinoma. Hum. Mutat. 29, 703–708 (2008).
Article CAS PubMed Google Scholar - Ferber, M.J. et al. Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers. Oncogene 22, 3813–3820 (2003).
Article CAS PubMed Google Scholar - Neuveut, C., Wei, Y. & Buendia, M.A. Mechanisms of HBV-related hepatocarcinogenesis. J. Hepatol. 52, 594–604 (2010).
Article CAS PubMed Google Scholar - Totoki, Y. et al. High-resolution characterization of a hepatocellular carcinoma genome. Nat. Genet. 43, 464–469 (2011).
Article CAS PubMed Google Scholar - Li, M. et al. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat. Genet. 43, 828–829 (2011).
Article CAS PubMed PubMed Central Google Scholar - Furuta, T. et al. Clinicopathologic features of hepatocellular carcinoma in young patients. Cancer 66, 2395–2398 (1990).
Article CAS PubMed Google Scholar - Kim, J.H. et al. Clinical features and prognosis of hepatocellular carcinoma in young patients from a hepatitis B–endemic area. J. Gastroenterol. Hepatol. 21, 588–594 (2006).
Article PubMed Google Scholar - Hao, K. et al. Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters. BMC Cancer 9, 389 (2009).
Article PubMed PubMed Central Google Scholar - Xu, X. et al. The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line. Nat. Biotechnol. 29, 735–741 (2011).
Article CAS PubMed PubMed Central Google Scholar - Chen, Y. et al. Complete genome sequence of hepatitis B virus (HBV) from a patient with fulminant hepatitis without precore and core promoter mutations: comparison with HBV from a patient with acute hepatitis infected from the same infectious source. J. Hepatol. 38, 84–90 (2003).
Article CAS PubMed Google Scholar - Trapnell, C., Pachter, L. & Salzberg, S.L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105–1111 (2009).
Article CAS PubMed PubMed Central Google Scholar - Mortazavi, A., Williams, B.A., McCue, K., Schaeffer, L. & Wold, B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 5, 621–628 (2008).
Article CAS PubMed Google Scholar - Lamb, J.R. et al. Predictive genes in adjacent normal tissue are preferentially altered by sCNV during tumorigenesis in liver cancer and may rate limiting. PLoS ONE 6, e20090 (2011).
Article CAS PubMed PubMed Central Google Scholar - Chiang, D.Y. et al. High-resolution mapping of copy-number alterations with massively parallel sequencing. Nat. Methods 6, 99–103 (2009).
Article CAS PubMed Google Scholar - Mermel, C.H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41 (2011).
Article PubMed PubMed Central Google Scholar
Acknowledgements
We gratefully acknowledge Y.-K. Mak and the clinical team of the Division of Hepatobiliary and Pancreatic Surgery (HBP) at Queen Mary Hospital. This study was funded by the Asian Cancer Research Group (ACRG), a not-for-profit organization formed by Eli Lilly, Merck and Pfizer. We thank S. Friend and G. Jin for initiating the establishment of ACRG. We are grateful to former and present members of ACRG, especially K. Blanchard, Y. Turpaz, J. Sedgwick, G. Tucker-Kellogg, G. Gilliland, P. Shaw, N. Gibson and S. Adams.
Author information
Author notes
- John M Luk
Present address: Present address: Department of Oncology, Roche R&D Center (China) Ltd., Shanghai, China., - Wing-Kin Sung, Hancheng Zheng, Shuyu Li, Ronghua Chen and Xiao Liu: These authors contributed equally to this work.
Authors and Affiliations
- Department of Surgery, University of Hong Kong, Hong Kong
Wing-Kin Sung, Nikki P Lee, Kwong F Wong, Angela M Liu, Ronnie T Poon, Sheung Tat Fan, Kwong L Chan & John M Luk - School of Computing, National University of Singapore (NUS), Singapore
Wing-Kin Sung & Chandana Tennakoon - NUS Graduate School for Integrative Sciences & Engineering, National University of Singapore, Singapore
Wing-Kin Sung & Chandana Tennakoon - Department of Computational & Systems Biology, Genome Institute of Singapore, Singapore
Wing-Kin Sung, Wah H Lee, Pramila N Ariyaratne & Fabianus H Mulawadi - Beijing Genomics Institute, Shenzhen, China
Hancheng Zheng, Xiao Liu, Yingrui Li, Zhuolin Gong, Yujie Hu, Zhao Lin, Guan Wang, Qinghui Zhang & Jun Wang - Eli Lilly & Co., Indianapolis, Indiana, USA
Shuyu Li, Thomas D Barber, Wen-Chi Chou, Amit Aggarwal & Christoph Reinhard - Merck Research Laboratories, Boston, Massachusetts, USA
Ronghua Chen, Ke Hao, Wei Zhou, Chunsheng Zhang, James Hardwick, Carolyn Buser & Hongyue Dai - Department of Pharmacology, NUS, Singapore
Kwong F Wong, Angela M Liu & John M Luk - Department of Surgery, NUS, Singapore
Kwong F Wong, Angela M Liu & John M Luk - Cancer Science Institute, NUS, Singapore
Kwong F Wong, Angela M Liu & John M Luk - Asian Cancer Research Group, Inc., Wilmington, Delaware, USA
James Hardwick & Mao Mao - Pfizer Oncology, San Diego, California, USA
Jiangchun Xu, Zhengyan Kan & Mao Mao - Department of Biology, University of Copenhagen, Copenhagen, Denmark
Jun Wang - The Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark
Jun Wang
Authors
- Wing-Kin Sung
You can also search for this author inPubMed Google Scholar - Hancheng Zheng
You can also search for this author inPubMed Google Scholar - Shuyu Li
You can also search for this author inPubMed Google Scholar - Ronghua Chen
You can also search for this author inPubMed Google Scholar - Xiao Liu
You can also search for this author inPubMed Google Scholar - Yingrui Li
You can also search for this author inPubMed Google Scholar - Nikki P Lee
You can also search for this author inPubMed Google Scholar - Wah H Lee
You can also search for this author inPubMed Google Scholar - Pramila N Ariyaratne
You can also search for this author inPubMed Google Scholar - Chandana Tennakoon
You can also search for this author inPubMed Google Scholar - Fabianus H Mulawadi
You can also search for this author inPubMed Google Scholar - Kwong F Wong
You can also search for this author inPubMed Google Scholar - Angela M Liu
You can also search for this author inPubMed Google Scholar - Ronnie T Poon
You can also search for this author inPubMed Google Scholar - Sheung Tat Fan
You can also search for this author inPubMed Google Scholar - Kwong L Chan
You can also search for this author inPubMed Google Scholar - Zhuolin Gong
You can also search for this author inPubMed Google Scholar - Yujie Hu
You can also search for this author inPubMed Google Scholar - Zhao Lin
You can also search for this author inPubMed Google Scholar - Guan Wang
You can also search for this author inPubMed Google Scholar - Qinghui Zhang
You can also search for this author inPubMed Google Scholar - Thomas D Barber
You can also search for this author inPubMed Google Scholar - Wen-Chi Chou
You can also search for this author inPubMed Google Scholar - Amit Aggarwal
You can also search for this author inPubMed Google Scholar - Ke Hao
You can also search for this author inPubMed Google Scholar - Wei Zhou
You can also search for this author inPubMed Google Scholar - Chunsheng Zhang
You can also search for this author inPubMed Google Scholar - James Hardwick
You can also search for this author inPubMed Google Scholar - Carolyn Buser
You can also search for this author inPubMed Google Scholar - Jiangchun Xu
You can also search for this author inPubMed Google Scholar - Zhengyan Kan
You can also search for this author inPubMed Google Scholar - Hongyue Dai
You can also search for this author inPubMed Google Scholar - Mao Mao
You can also search for this author inPubMed Google Scholar - Christoph Reinhard
You can also search for this author inPubMed Google Scholar - Jun Wang
You can also search for this author inPubMed Google Scholar - John M Luk
You can also search for this author inPubMed Google Scholar
Corresponding authors
Correspondence toChristoph Reinhard, Jun Wang or John M Luk.
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Rights and permissions
About this article
Cite this article
Sung, WK., Zheng, H., Li, S. et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma.Nat Genet 44, 765–769 (2012). https://doi.org/10.1038/ng.2295
- Received: 23 January 2012
- Accepted: 30 April 2012
- Published: 27 May 2012
- Issue Date: July 2012
- DOI: https://doi.org/10.1038/ng.2295